Leena Gandhi - 04 Apr 2023 Form 4 Insider Report for NexImmune, Inc.

Role: Director
Signature: /s/John Rudy, attorney-in-fact
Issuer symbol: NEXI on OTC
Transactions as of: 04 Apr 2023
Net transactions value: $0
Form type: 4
Filing time: 06 Apr 2023, 20:43:55 UTC
Previous filing: 09 May 2022
Next filing: 07 Jul 2023
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Shares	Change %	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NEXI	Stock Option (right to buy)	Disposed to Issuer	-80,947	-100%	0	04 Apr 2023	Common Stock	80,947	$3.07	Direct	F1
transaction	NEXI	Stock Option (right to buy)	Award	+35,976		35,976	04 Apr 2023	Common Stock	35,976	$1.64	Direct	F1
transaction	NEXI	Stock Option (right to buy)	Award	+44,971		44,971	04 Apr 2023	Common Stock	44,971	$1.23	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 5, 2022, of which 24,733 shares vested, and the remainder of the options will vest in equal monthly installments such that on May 5, 2025, all shares subject to the option shall be vested, subject to Ms. Gandhi's continued service on each vesting date.

Content

The reported transactions involved an amendment of an outstanding stock option grant, resulting in the deemed cancellation of the old option and the grant of a replacement option. The option was originally granted on May 5, 2022, of which 24,733 shares vested, and the remainder of the options will vest in equal monthly installments such that on May 5, 2025, all shares subject to the option shall be vested, subject to Ms. Gandhi's continued service on each vesting date.